Answers are grounded in this paper and cite their sources.
Novel ci-fGBD framework enhances clustering of multimodal data in Alzheimer disease, suggesting improved patient stratification.
Multimodal biomedical datasets, such as those from neurodegenerative disease cohorts, present significant challenges in stratifying heterogeneous patient populations due to missing values, high dimensionality, and modality-specific biases. Traditional clustering methods often require extensive preprocessing and fail to integrate heterogeneous data types effectively. We introduce ci-fGBD(Cluster-Integrated Fast Generalized Bruhat Decomposition), a novel matrix factorization and clustering framework that natively operates on block-structured, multimodal datasets. ci-fGBD extends the classical Bruhat decomposition by jointly learning latent representations and patient clusters while automatically harmonizing contributions across diverse modalities, including neuroimaging, cognitive assessments, genomics, wearable sensors, and environmental exposures. Benchmarking against standard methods on real datasets demonstrates that ci-fGBD consistently identifies clinically meaningful subgroups, capturing subtle biological, cognitive, and demographic heterogeneity in Alzheimer disease cohorts with superior interpretability and robustness.
No takes yet. Share an insight, caveat, or question.
Thakur et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: